GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » Other Current Payables

Cybin (CYBN) Other Current Payables : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Cybin Other Current Payables?

Cybin's Other Current Payables for the quarter that ended in Dec. 2023 was $0.00 Mil.

Cybin's annual Other Current Payables increased from Mar. 2021 ($1.68 Mil) to Mar. 2022 ($2.09 Mil) but then declined from Mar. 2022 ($2.09 Mil) to Mar. 2023 ($0.00 Mil).


Cybin Other Current Payables Historical Data

The historical data trend for Cybin's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Other Current Payables Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Other Current Payables
- 1.68 2.09 -

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cybin Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Cybin Other Current Payables Related Terms

Thank you for viewing the detailed overview of Cybin's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Cybin (CYBN) Business Description

Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.